Abstract:Abstract Background It has been demonstrated by studies globally that RNA binding proteins (RBPs) took part in the development of cervical cancer (CC). Few studies concentrated on the correlation between RBPs and overall survival of CC patients. We retrieved significant DEGs (differently expressed genes, RNA binding proteins) correlated to the process of cervical cancer development. Methods Expressions level of genes in cervical cancer and normal tissue samples were obtained from GTEx and TCGA database. Differently expressed RNA binding proteins (DEGs) were retrieved by Wilcoxon sum-rank test. ClusterProfiler package worked in R software was used to perform GO and KEGG enrichment analyses. Univariate proportional hazard cox regression and multivariate proportional hazard cox regressions were applied to identify DEGs equipped with prognostic value and other clinical independent risk factors. ROC curve was drawn for comparing the survival predict feasibility of risk score with other risk factors in CC patients. Nomogram was drawn to exhibit the prediction model and validated by C-index and calibration curve. Correlations between differentially expressed RNA binding proteins (DEGs) and other clinical features were investigated by t test or Cruskal Wallis analysis. Correlation between Immune and DEGs in cervical cancer was investigated by ssGSEA. Results 347 differentially expressed RBPs (DEGs) were retrieved from cervical cancer tissue and normal tissue samples. GO enrichment analysis showed that these DEGs involved in RNA splicing, catabolic process and metabolism. Cox regression model showed that there were ten DEGs significantly associated with overall survival of cervical cancer patients. WDR43 (HR = 0.423, P = 0.008), RBM38 (HR = 0.533, P < 0.001), RNASEH2A (HR = 0.474, P = 0.002) and HENMT1 (HR = 0.720, P = 0.071) played protective roles in survival among these ten genes. Stage (Stage IV vs Stage I HR = 3.434, P < 0.001) and risk score (HR = 1.214, P < 0.001) were sorted as independent prognostic risk factors based on multivariate cox regression. ROC curve validated that risk score was preferable to predict survival of CC patients than other risk factors. Additionally, we found some of these ten predictor DEGs were correlated significantly in statistic with tumor grade or stage, clinical T stage, clinical N stage, pathology or risk score (all P < 0.05). Part of immune cells and immune functions showed a lower activity in high risk group than low risk group which is stratified by median risk score. Conclusion Our discovery showed that many RNA binding proteins involved in the progress of cervical cancer, which could probably serve as prognostic biomarkers and accelerate the discovery of treatment targets for CC patients.

Identification and Characterization of Genes with Absolute Mrna Abundances Changes in Tumor Cells with Varied Transcriptome Sizes

Rna-Sequence Analysis Reveals Differentially Expressed Genes (degs) in Patients Exhibiting Different Risks of Tumor Metastasis

Identification and analysis of DEGs of mouse tumor cells by integrated bioinformatics methods

Comparative analysis of oncogenes identified by microarray and RNA-sequencing as biomarkers for clinical prognosis.

Differential Expression Analysis for Individual Cancer Samples Based on Robust Within-Sample Relative Gene Expression Orderings Across Multiple Profiling Platforms

High heterogeneity undermines generalization of differential expression results in RNA-Seq analysis

Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.

Expression profile of RNA binding protein in cervical cancer using bioinformatics approach

Transcriptional Profiling Analysis And Functional Prediction Of Long Noncoding Rnas In Cancer

Global Differential Gene Expression in Cancers and its Implications for Building Robust Diagnostic Classifiers

Computational Characterization of Undifferentially Expressed Genes with Altered Transcription Regulation in Lung Cancer

Comparison of Mrna and Protein Expression Profiles Between Adenoid Cystic Carcinoma High and Low Metastatic Cell Lines

Analysis Of Mrna Profile In Different Strategy Of Bladder Cancer Carcinoma By Deep Sequencing

Identification of Two Novel Biomarkers of Rectal Carcinoma Progression and Prognosis Via Co-Expression Network Analysis

Identification of Genes with Universally Upregulated or Downregulated Expressions in Colorectal Cancer.

Individualized Analysis Of Differentially Expressed Mirnas With Application To The Identification Of Mirnas Deregulated Commonly In Lung Cancer Tissues

Transcriptome Profiling of Prostate Tumor and Matched Normal Samples by RNA-Seq

Systematic Characterization of Cancer Transcriptome at Transcript Resolution

Personalized differential expression analysis in triple-negative breast cancer

A Survey of Regulatory Interactions among RNA Binding Proteins and MicroRNAs in Cancer

Identification of Novel Biomarkers for Hepatocellular Carcinoma Using Transcriptome Analysis.